This article has Open Peer Review reports available.
Pembrolizumab for metastatic melanoma in a renal allograft recipient with subsequent graft rejection and treatment response failure: a case report
© The Author(s). 2017
Received: 5 September 2016
Accepted: 1 February 2017
Published: 19 March 2017
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|5 Sep 2016||Submitted||Original manuscript|
|3 Nov 2016||Reviewed||Reviewer Report - aisha alosail|
|3 Nov 2016||Reviewed||Reviewer Report - shoba theivanayagam|
|22 Dec 2016||Author responded||Author comments - Vineet Kwatra|
|Resubmission - Version 2|
|22 Dec 2016||Submitted||Manuscript version 2|
|26 Dec 2016||Reviewed||Reviewer Report - aisha alosail|
|2 Jan 2017||Reviewed||Reviewer Report - shoba theivanayagam|
|16 Jan 2017||Author responded||Author comments - Vineet Kwatra|
|Resubmission - Version 3|
|16 Jan 2017||Submitted||Manuscript version 3|
|23 Jan 2017||Reviewed||Reviewer Report - aisha alosail|
|26 Jan 2017||Reviewed||Reviewer Report - shoba theivanayagam|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|1 Feb 2017||Editorially accepted|
|19 Mar 2017||Article published||10.1186/s13256-017-1229-z|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.